Trademark Services · Pharmaceutical
Pharmaceutical Trademark Attorney in Orange County, CA
mjIP advises pharmaceutical companies on trademark clearance, registration, and enforcement, with attention to the naming rules unique to the industry. Founding attorney Mandana Jafarinejad, Esq. brings Fortune 500 pharmaceutical experience to drug-brand strategy — an understanding of both USPTO and FDA-related naming considerations. Part of the firm's trademark services.
Drug Brand Naming, Done Carefully
- Clearance searches for proprietary drug and product names
- Attention to FDA nonproprietary-name differentiation and naming guidance
- Trade-dress considerations for packaging and presentation
- USPTO registration, monitoring, and enforcement
Two Naming Systems at Once
Pharmaceutical brands must satisfy trademark law and FDA-related naming expectations at the same time. mjIP helps navigate both so a chosen name is registrable and viable as the product moves toward market. Coordinate with a pharmaceutical patent attorney on the underlying drug IP.
Common Questions
Frequently Asked Questions
Drug names must work under trademark law and also account for FDA guidance meant to avoid confusion with existing names. A name may clear one system and fail the other, so both must be considered together.
Before committing to it — ideally early in development, since renaming a therapeutic late is costly and disruptive.